NCT02138799View on ClinicalTrials.gov

A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Drug-Drug Interaction (DDI)Healthy SubjectsPharmacokinetics of Enzalutamide

Interventions

DRUG

enzalutamide

oral

DRUG

rifampin

oral

Trial Locations (1)

14050

Parexel International GmbH, Berlin

Sponsors

Collaborators (1)

Medivation, Inc.

All Listed Sponsors

collaborator

Medivation, Inc.

INDUSTRY

lead

Astellas Pharma Europe B.V.

INDUSTRY